Рефераты. Функциональный запор: вопросы диагностики и терапевтические подходы (обзор литературы)

Gastroenterology 2001;120:652-668.

122. Cann PA, Read NW, Holdsworth CD. What is the benefit of coarse wheat

bran in patients with irritable bowel syndrome? Gut 1984;25:165-173.

123. Celik AF, Tomlin J, Read NW. The effect of oral vancomycin on chronic

idiopathic constipation. Aliment Pharmacol Ther. 1995;9:63-8.

124. Chadwick VS et Phillips SF. // Gastroenterology, 1982, v.2.

125. Chaussade S, Roche H, Khyardi A, et al. A new method for measuring

colonic transit time. Description and validation. Gastroenterol Clin

Biol 1986;10:385-389.

126. Chaussade S. Determination of total and segmental colonic transit time

in constipated patients. Results in 91 patients with a new simplified

method. Dig Dis Sci 34:1168-1172, 1989 Aug.

127. Chiotakakou-Faliakou E; Kamm MA; Roy AJ; Storrie JB; Turner IC.

Biofeedback provides long-term benefit for patients with intractable,

slow and normal transit constipation. Gut, 42(4):517-21 1998 Apr.

128. Chong-Liang HE, Burghardt L, Wang L, Pemberton J et al. Decreased

intestinal cell of Cojal volume in patients with slow-transit

constipation. Gastroenterology, 2000;118:14-21.

129. Connell AM, Hilton C, Irvine G, et al. Variation in bowel habit in two

population samples. Br Med J 1965;2:1095.

130. Corazziari E, Badiali D, Bazzocchi G, Bassotti G, Roselli P,

Mastropaolo G et al. Long term efficacy, safety, and tolerabilitity of

low daily doses of isosmotic polyethylene glycol electrolyte balanced

solution (PMF-100) in the treatment of functional chronic

constipation. Gut 2000;46:522-526 (April)

131. Coremans G, Kerstens R, Woods M. Dose-ranging efficacy, safety and

tolerability of prucalopride in patients with chronic constipation:

Results of two randomized, placebo-controlled, double-blind trials. Am

J Gastroenterol 1999;94(9):2669 (Abstract).

132. Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N,

Cedarbaum JM. Recombinant Human Neurotrophic Factors Accelerate

Colonic Transit and Relieve Constipation in Humans. Gastroenterology

2000;119:41-50.

133. Couturier D. Comparative study of Forlax and Transipeg in the

treatment of functional constipation in the adult. Ann Gastroenterol

Hepatol (Paris), 1996 May-Jun, 32:135-40.

134. Cremerius J. Die Prognose funktioneller Syndrome.- Leipzig, 1968,

s.134.

135. Сummings J., Kelly M.J., Smith C.L.: The significance of propulsive,

retropulsive and segmenting contractions of the colon and rectum in

the irritable bowel syndrome // Gut.- 1983.- Vol.24.- P.368-368.

136. Cummings JH. Quantitating short chain fatty acid production in humans.

In: Short chain fatty acids/ Falk Symposium 73; Kluwer Academic

Publishers, 1994, 11-19.

137. Davies GJ, Crowder M, Reid B, Dickerson JWT. Bowel function

measurements of individuals with different eating patterns. Gut

1986;27:164.

138. de Graaf EJ; Gilberts EC; Schouten WR. Role of segmental colonic

transit time studies to select patients with slow transit constipation

for partial left-sided or subtotal colectomy. Br J Surg, 83(5):648-51

1996 May

139. Delvaux M, Frexinos J. A European approach to irritable bowel syndrome

management. Can J Gastroenterol 1999 Mar;13 Suppl A:85A-88A.

140. Devroede G. Constipation. In: Sleisenger MH, Fordtran JS, eds.

Gastrointestinal disease: pathophysiology, diagnosis and management.

4th ed. Philadelphia: WB Saunders, 1989:331.

141. Diamant NE, Kamm MA, Wald A, et al. American Gastroenterologic

Association technical review on anorectal testing techniques.

Gastroenterology 1999;116:735-60.

142. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MvB. A

randomized, placebo-controlled, multicenter study of the safety and

efficacy of Braintree 851 laxative. Am J Gastroenterol (abstract)

1997;92:1674.

143. DiPalma JA, MacRae DH, Reichelderfer M, Hamilton JW, Cleveland MvB.

Braintree polyethylene glycol (PEG) laxative for ambulatory and long-

term care facility constipation patients: report of randomized, cross-

over trials. Braintree Laboratories Inc., Braintree, MA;

http://www.ojdh.org/current.dir/dipalma%5Fbraintree.html

144. Dodds WJ, Dent J, Hogan WJ. Pregnancy and the lower esophageal

sphincter. Gastroenterology 1978;74:1334.

145. Drossman DA, Sandler RS, McKee DC, et al: Bowel patterns among

subjects not seeking health care. Use of a questionnaire to identify a

population with bowel dysfunction. Gastroenterology 83:529-534, 1982.

146. Drossman DA, ed. The functional gastrointestinal disorders. Boston:

Little, Brown, 1994:115-173.

147. Drossman DA Diagnosing and treating patients with refractory

functional gastrointestinal disorders. Ann Intern Med 1995;123:688-

693.

148. Drossman DA, Creed FH, Fava GA, Olden KW, Patrick DL, Toner BB,

Whitehead WE. Psychosocial aspects of the functional gastrointestinal

disorders. Gastroenterology International 1995;8:47-90.

149. Drossman DA, Camilleri M, Whitehead WE. American Gastroenterological

Association technical review on irritable bowel syndrom.

Gastroenterology 1998; 95: 701-8.

150. Eastwood MA, Robertson JA, Brydon WG, Macdonald D. Measurement of

water-holding properties of fibre and their faecal bulking ability in

man. Br J Nutr. 1983:50:539-47.

151. Edwards CA. The physiological effects of dietary fiber. In: Krichevsky

D, Bonfield C, editors. Dietary fiber in health and disease. St Paul,

MN: Eagan Press; 1995:58-71.

152. Eisen GA, Locke GR, Provenzale D. Health-related quality of life: a

primer for gastroenterologists. Am J Gastroenterol 1999; 94: 2017-21.

153. Ekberg O, Nylander G, Fork F. Defecography. Radiology 1985;155:45-48.

154. Emmanuel AV, Kamm MA. Laser Doppler flowmetry as a measure of

extrinsic colonic innervation in functional bowel disease. Gut,

2000;46;212-7.

155. Everhart JE, Go VLW, Johannes RS, Fitzsimmons SC, Roth HP, White LR. A

longitudinal survey of self-reported bowel habits in the United

States. Dig Dis Sciences, Vol. 34, No.8 (August 1989), p.1153-1162.

156. Everson GT, McKinley C, Lawson M, et al. Gallbladder function in the

human female: effect of the ovulatory cycle, pregnancy and

contraceptive steroids. Gastroenterology 1982;82:711.

157. Ewe K. Medikamentцse Therapie der Obstipation. In: Mьller-Lissner SA,

Akkermans LMA, editors. Chronische Obstipation und Stuhlinkontinenz.

Berlin: Springer Verlag; 1989:267-86.

158. Freimanis MG, Wald A, Caruana B, Bauman DH. Evacuation proctolography

in normal volunteers. Invest Radiol 1991:26:581-585.

159. Gekas P, Schuster MM. Stercoral perforation of the colon: case report

and review of the literature. Gastroenterology 1981;80:1054.

160. Gilliland R; Heymen S; Altomare DF; Park UC; Vickers D; Wexner SD.

Outcome and predictors of success of biofeedback for constipation. Br

J Surg, 84(8):1123-6 1997 Aug.

161. Glia A, Lindberg G. Quality of life in patients with different types

of functional constipation. Scand J Gastroenterol, 32(11):1083-9 1997

Nov

162. Goebell H. Acute und chronische Obstipation - ein Problem der Praxis

// Therapiewoche.- 1977.- Bd.27/- S.2427-2434.

163. Gorbatchef C, Jouлt P, Coffin B, Flourie B, Lemann M. Effects of short-

chain fatty acids on the phasic and tonic motor activity in the

unprepared colon of healthy humans. Gastroenterology 1998;114: G3119.

164. Gordon PH, Nivatvongs S. Principles and practice of surgery for the

colon, rectum and anus. Second edition. Quality Medical Publishing,

Inc., St.Louis, Missouri, 1999, p.1457.

165. Grotz RL; Pemberton JH; Talley NJ; Rath DM; Zinsmeister AR.

Discriminant value of psychological distress, symptom profiles, and

segmental colonic disfunction in outpatients with severe idiopathic

constipation. Gut, 35(6):798-802 1994 Jun.

166. Joo JS, Agachan F, Wolff B, Nogueras JJ, Wexner SD. Initial North

American experience with botulinum toxin type A for treatment of

anismus. Dis Colon Rectum 39:1107-1111, 1996.

167. Haderstorfer B , Psycholgin D , Whitehead WE , Schuster MM.

Intestinal gas production from bacterial fermentation of undigested

carbohydrate in irritable bowel syndrome. Am J Gastroenterol, 84(4):

375-8 1989

168. Hahn BA, Kirchdoerfer U, Fullerton S, Mayer E. Evaluation of a new

quality of life questionnaire for patients with irritable bowel

syndrome. Aliment Pharmacol Ther 1997; 11: 547-52.

169. Halverson AL, Orkin BA. Which physiologic tests are useful in patients

with constipation? Dis Colon Rectum 41:735-9,1998 June.

170. Hamilton JW; Wagner J; Burdick BB; Bass P. Clinical evaluation of

methylcellulose as a bulk laxative. Dig Dis Sci, 33(8):993-8 1988 Aug.

171. Hammer HP, Santa Ana CA, Schiller LR, et al. Studies of osmotic

diarrhea induced in normal subjects by ingestion of polyethylene

glycol and lactulose. J Clin Invest 1989,84:1056-62.

172. Handbook of gastroenterology /editor Tadataka Yamada. Lippincott-Raven

Publishers, Phyladelphia, New York, 1998, 726 p., illustr.

173. Harvey RF; Mauad EC; Brown AM. Prognosis in the irritable bowel

Страницы: 1, 2, 3, 4, 5



2012 © Все права защищены
При использовании материалов активная ссылка на источник обязательна.